FDA.reportPublic FDA data

Hizentra 20 % in 10 ML Prefilled Syringe

RxCUI
2268109
RxNorm name
Hizentra 20 % in 10 ML Prefilled Syringe
Display name
Hizentra 20 % in 10 ML Prefilled Syringe
Full name
Hizentra 20 % in 10 ML Prefilled Syringe
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125350HizentraImmune Globulin Subcutaneous (Human), 20% Liquid351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
7b58f5ff-0316-49a3-b585-1f6003ddb953Hizentra 20 % in 10 ML Prefilled SyringePSN26These highlights do not include all the information needed to use HIZENTRA ® safely and effectively. See full prescribing information for HIZENTRA. HIZENTRA, Immune Globulin Subcutaneous (Human), 20% Liquid Initial U.S. Approval: 201020230420
7b58f5ff-0316-49a3-b585-1f6003ddb95310 ML immunoglobulin G, human 200 MG/ML Prefilled Syringe [Hizentra]SBD26These highlights do not include all the information needed to use HIZENTRA ® safely and effectively. See full prescribing information for HIZENTRA. HIZENTRA, Immune Globulin Subcutaneous (Human), 20% Liquid Initial U.S. Approval: 201020230420
7b58f5ff-0316-49a3-b585-1f6003ddb95310 ML Hizentra 200 MG/ML Prefilled SyringeSY26These highlights do not include all the information needed to use HIZENTRA ® safely and effectively. See full prescribing information for HIZENTRA. HIZENTRA, Immune Globulin Subcutaneous (Human), 20% Liquid Initial U.S. Approval: 201020230420
7b58f5ff-0316-49a3-b585-1f6003ddb953Hizentra 2 GM per 10 ML Prefilled SyringeSY26These highlights do not include all the information needed to use HIZENTRA ® safely and effectively. See full prescribing information for HIZENTRA. HIZENTRA, Immune Globulin Subcutaneous (Human), 20% Liquid Initial U.S. Approval: 201020230420